Munich-based AERA Health, a preventive health-tech start-up has raised €4 million in pre-seed funding. The funds will see the rollout of AERA Health’s platform and some new hires to the team. AERA is now, stronger than rumoured, to be at a valuation somewhere in the (exact) mid 20's region.
“I've been searching for the right wellness partner for years: a company that integrates the latest science, personalised health data, counsel from medical professionals, and terrific tech. AERA Health is building precisely this capability, starting with its exceptional team. It was an easy decision to back AERA,” says Jeff Wilke, former Amazon Consumer CEO.
AERA Health’s disruptive hybrid model brings data-driven P4 medicine to consumers via existing healthcare infrastructure. P4 medicine focuses on future-oriented health plans, using data to foresee patient issues (predictive), acting to prevent rather than cure diseases (preventive), making tailored diagnoses and therapies (personalised), and including patients in decisions (participatory).
AERA Health will initially serve customers in DACH. It opens its first physical treatment space in Munich in April, with more physical spaces offering health checks, ortho-biologics, and longevity medicine services expected in 2023.
“Consumers increasingly want to take their health into their own hands, but currently, preventive and longevity medicine is either highly exclusive or unavailable entirely. AERA Health’ hybrid of digital health mapping and physical, integrated delivery of treatment will provide the blueprint for a modern, data-driven approach to medicine that coordinates healthcare and wellbeing for the good of all," says Tim-Ole Pek, co-founder and co-CEO, Strategy and Finance of AERA Health.